| "Genetically Modified Products ( GMP ) " in this thesis refers to plant cultivars or relevant products that have been developed through recombinant deoxyribonucleic acid ("recombinant DNA") technology. Since there may be uncertain risks to human, animal, plant life and health as well as the environment with the Genetically Modified Products (GMP), many countries, including China, adopted strict safe measures to the Genetically Modified Products. In April 2003, the US, Canada and Argentina suited in WTO against European Community(UC), for EC suspended its confirmation for market access of the Genetically Modified Products since 1998. In 21 December 2006, Dispute Settlement Body of WTO adopted the Panel Report on EC - Affecting the Approval and Marketing of Biotech Products, which initiated the consideration of the study on the regulation relating to the Genetically Modified Products under the WTO.This thesis makes specific analysis on the Panes Report and three different WTO multilateral agreements, including GATT1994, the Agreement on the Application of Sanitary and Phytosanitary Measures (SPS Agreement) and the Agreement on Technical Barrier to Trade, and come to the following conclusion: The agreements under the frame WTO are very fuzzy and more explanation will be needed. The final ruling of the Panel Report is far from the resolution of this dispute, and further discussion in a broader view will be needed. And it also makes some recommendations, with the purpose to offer a reference for the decision of relevant government agencies. |
